SAGIMET’S LICENSE PARTNER ASCLETIS ANNOUNCED ACCEPTANCE OF NEW DRUG APPLICATION FOR DENIFANSTAT FOR THE TREATMENT OF MODERATE TO SEVERE ACNE BY CHINA’S NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Reuters · 2d ago

Please log in to view news